Clinical Trial

Comparison Between Carbapenems and Noncarbapenem Beta-lactam Antibiotics in Septic Burn Patients

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated October 3, 2025 (before its estimated January 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this work is to evaluate the efficacy associated with Meropenem(example of carbapenems) as initial therapy for sepsis in burn patients compared with Pipracillin/Tazobactam (example of non carbapenem beta lactam antibiotics).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-24.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-09-30
Trial Details
NCT Number NCT07096310
Lead Sponsor Ain Shams University
Conditions Sepsis
Enrollment 400 participants
Start Date 2024-01-01
Primary Completion 2026-01-15 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-10-03